-
141
Hidradenitis suppurativa induced by ipilimumab and nivolumab: A rare association
Published 2025-03-01Subjects: Get full text
Article -
142
Editorial: Tertiary lymphoid structures (TLS) in the tumor immune microenvironment
Published 2025-01-01Subjects: Get full text
Article -
143
Pathological Complete Response to a Single Dose of Pembrolizumab‐Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case Report
Published 2025-01-01Subjects: “…immune checkpoint inhibitors…”
Get full text
Article -
144
Targeting NANOS1 in triple-negative breast cancer: synergistic effects of digoxin and PD-1 inhibitors in modulating the tumor immune microenvironment
Published 2025-01-01Subjects: “…immune checkpoint blockade…”
Get full text
Article -
145
-
146
Efficacy and safety of first-line nivolumab plus ipilimumab treatment in elderly patients (aged ≥ 75 years) with non-small cell lung cancer
Published 2025-01-01Subjects: Get full text
Article -
147
Biomarkers in metastatic castration-resistant prostate cancer for efficiency of immune checkpoint inhibitors
Published 2025-12-01Subjects: Get full text
Article -
148
-
149
The effect of baseline versus early glucocorticoid use on immune checkpoint inhibitor efficacy in patients with advanced NSCLC
Published 2025-01-01Subjects: Get full text
Article -
150
-
151
Late-onset and relapsed cytokine release syndrome after nivolumab treatment in a patient with head and neck squamous cell carcinoma: a case report
Published 2025-02-01Subjects: “…immune checkpoint inhibitor…”
Get full text
Article -
152
-
153
-
154
Case report: Multi-organ injuries induced by tislelizumab
Published 2025-02-01Subjects: Get full text
Article -
155
Sinonasal small-cell carcinoma combined concurrently with small-cell lung carcinoma: case report and literature review
Published 2025-01-01Subjects: Get full text
Article -
156
Lower respiratory tract microbiome dysbiosis impairs clinical responses to immune checkpoint blockade in advanced non‐small‐cell lung cancer
Published 2025-01-01Subjects: Get full text
Article -
157
Increased serum soluble PD-l1 levels in patients with advanced stages of chronic kidney disease
Published 2025-01-01Subjects: Get full text
Article -
158
-
159
Machine-Learning Parsimonious Prediction Model for Diagnostic Screening of Severe Hematological Adverse Events in Cancer Patients Treated with PD-1/PD-L1 Inhibitors: Retrospective...
Published 2025-01-01Subjects: “…immune checkpoint inhibitor…”
Get full text
Article -
160
Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy
Published 2025-02-01Subjects: Get full text
Article